Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.
<h4>Purpose</h4> <p>CHEK2*1100delC is a founder variant in European populations that confers a two- to threefold increased risk of breast cancer (BC). Epidemiologic and family studies have suggested that the risk associated with CHEK2*1100delC is modified by other genetic factors...
Lignende værker
-
Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.
af: Schmidt, M, et al.
Udgivet: (2016) -
Cohort profile: a nationwide study in Dutch CHEK2 c.1100delC families using the infrastructure of the HEreditary Breast and Ovarian cancer study Netherlands – Hebon-CHEK2
af: Rosa de Groot, et al.
Udgivet: (2024-10-01) -
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival
af: Anna Morra, et al.
Udgivet: (2023-08-01) -
Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile
af: Marcel Smid, et al.
Udgivet: (2023-05-01) -
Pathogenesis and clinical features of congenital stationary night blindness in case of c.283delC NYX gene mutation
af: M. E. Ivanova, et al.
Udgivet: (2019-08-01)